Trial Profile
Phase I Study of the Safety and Immunogenicity of AMA1-C1/Alhydrogel + CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Agatolimod (Primary) ; Malaria vaccine (Primary) ; Aluminium hydroxide
- Indications Falciparum malaria
- Focus Adverse reactions; Pharmacodynamics
- 29 Jul 2010 New trial record